2 May 2014
Last updated at 09:28
US drugs giant Pfizer has raised the price it is offering for AstraZeneca to £50 a share, valuing the firm at £63bn.
Pfizer’s initial offer in January was worth £46.61 per AstraZeneca share, and was rejected by the UK firm.
If successful,…
Pfizer raises AstraZeneca offer
No comments:
Post a Comment